CytomX Therapeutics (CTMX)
(Delayed Data from NSDQ)
$1.19 USD
+0.02 (1.71%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $1.18 -0.01 (-0.84%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth D Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/05/2024
Time: -- |
9/2024 | $-0.12 | 26.23% |
Earnings Summary
For their last quarter, CytomX Therapeutics (CTMX) reported earnings of -$0.08 per share, missing the Zacks Consensus Estimate of -$0.07 per share. This reflects a negative earnings surprise of 14.29%. Look out for CTMX's next earnings release expected on November 05, 2024. For the next earning release, we expect the company to report earnings of -$0.12 per share, reflecting a year-over-year decrease of 400%.
Earnings History
Price & Consensus
Zacks News for CTMX
Vanda (VNDA) to Report Q1 Earnings: What's in the Cards?
CTMX: What are Zacks experts saying now?
Zacks Private Portfolio Services